ProNAi: J.P.Morgan Healthcare Conference (ProNAi) - Jan 28, 2016 - Anticipated interim data from P2 BRIGHTON trial (NCT02378038) in Richter's transformation in 2016; Anticipated
initiation of P2 CYPRESS trial in R/R 2nd-line DLBCL transplant eligible + R-ICE in 2016; Anticipated initiation of P2 GRANITE trial in R/R 2nd-line DLBCL transplant ineligible + BR in 2016; Anticipated initiation of single-agent P2 trial in hematological indications in 2016; Anticipated initiation of P2 combination trial in other DLBCL + target agent in 2016
Anticipated new P2 trial • Anticipated P2 data • Non-Hodgkin's Lymphoma • Oncology
|